Zhao Jun

Professional Biography

Dr. Zhao Jun is Chief Physician in Thoracic Oncology at Peking University Cancer Hospital, Beijing. Zhao serves as Vice Director, Department of Thoracic Oncology I. Clinical expertise includes Non-small cell lung cancer (NSCLC) — immunotherapy and targeted therapy, Squamous cell lung cancer — PD-1/PD-L1-based first-line treatment, Small cell lung cancer (SCLC) — extensive-stage systemic therapy, MET-amplified NSCLC — targeted therapy (vebreltinib, savolitinib). Contributing investigator on RATIONALE-307 subgroup analyses and SAFFRON-301 Phase III trial of sitravatinib + tislelizumab versus docetaxel in previously treated advanced NSCLC — published in BMJ Oncology 2026 (PMID: 41737914). Postdoctoral Fellowship, University of Maryland, USA (2010–2012). University of Maryland postdoctoral fellowship (2010–2012) — US-trained lung cancer specialist with international clinical trial experience.